IRISH FIRM CROSPON UNVEILS ENDOFLIP GASTROENTEROLOGY.

Biotech Equipment Update, July, 2009

Underscoring Ireland's emergence as an innovation leader in gastroenterology technology and treatment, a host of Irish companies from across the country and across a range of medical and pharmaceutical disciplines are traveling to Chicago, Illinois to showcase their innovations at the upcoming Digestive Disease Week (DDW) Conference. Prominent among those companies is Crospon of Galway, a medical device pioneer that just agreed to a worldwide distribution deal for its flagship gastroenterology product, EndoFLIP, a diagnostic tool for assessing the competence of the gastroesophageal junction in patients with gastroesophageal reflux disorder (GERD).

Uniquely, EndoFLIP challenges the gastroesophageal junction to test its compliance. The system consists of a probe,...

Read the rest of this article with a Free Trial at HighBeam Research.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works.